NYSE · Drug Manufacturers - General

Johnson & Johnson (JNJ) Stock

$259.24 +0.88% NYSE: JNJ Healthcare

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments.

Valuation

MetricValue
Price$259.24
Market Cap$624.74B
P/E Ratio29.91
P/B Ratio7.81
P/S Ratio6.48
EPS (TTM)$11.03
52-Week High$269.58
52-Week Low$154.21
Dividend Yield2.07%

Financials & Margins

MetricValue
ROE26.26%
ROA10.47%
ROCE18.08%
Gross Margin69.12%
Operating Margin26.87%
Net Margin21.83%
Debt/Equity0.68
Current Ratio1.03

Annual Financials (USD)

Metric20212022202320242025
Revenue$78.7B$80.0B$85.2B$88.8B$94.2B
Operating Profit$20.9B$21.0B$23.4B$22.1B$25.6B
Net Profit$20.9B$17.9B$35.2B$14.1B$26.8B
EPS$7.81$6.73$13.72$5.79$11.03
Op Margin26.6%26.3%27.5%24.9%27.2%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$182.0B$187.4B$167.6B$180.1B$199.2B
Total Liabilities$108.0B$110.6B$98.8B$108.6B$117.7B
Cash$14.5B$12.9B$21.9B$24.1B$19.7B
Borrowings$33.8B$39.6B$29.3B$36.6B$47.9B

Latest News

The Dividend Growth Plan That Leaves High-Yield Stocks Behind 24/7 Wall St. · Jul 11, 2026 Why Today’s Small Dividend Could Become Tomorrow’s Retirement Engine 24/7 Wall St. · Jul 11, 2026 The Retirement Budget Most People Build Is Backward 24/7 Wall St. · Jul 11, 2026 Volatility Isn’t the Risk You Should Fear — These Are 24/7 Wall St. · Jul 11, 2026 Should You Buy Eli Lilly Stock? Here's My Honest Take. Motley Fool · Jul 11, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$23.4B$21.2B$22.8B$24.3B$24.5B
Investing Cash Flow$-12.3B$-16.4B$-3.7B$-23.0B$-28.4B
Financing Cash Flow$-2.0B$-4.6B$-5.6B$-1.4B$-2.8B
Net Cash Flow$502.0M$-360.0M$7.7B$2.2B$-4.4B
Free Cash Flow$19.8B$17.2B$18.2B$19.8B$19.7B

Valuation & Return Ratios

MetricValue
PEG Ratio-6.78
EV / EBITDA19.64
FCF Yield2.85%
Quick Ratio0.77
Interest Coverage24.92
Return 1Y63.03%
Return 3Y67.46%
Return 5Y78.95%

Ownership

Insiders Held0.05%
Institutions Held76.85%
Institutions Float Held76.89%
Institutional HolderSharesReport Date
Blackrock Inc.213,385,5462026-03-31
Vanguard Capital Management LLC156,605,3702026-03-31
State Street Corporation133,476,2882026-03-31
Vanguard Portfolio Management LLC63,514,4362026-03-31
JPMORGAN CHASE & CO63,096,3442026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ABBVAbbVie Inc. $246.04 +0.89% 127.26 $434.70B 2.58%
AMGNAmgen Inc. $387.64 -1.39% 23.42 $209.21B 2.82%
AZNAstraZeneca PLC $173.30 +0.48% 29.74 $134.31B 1.69%
GILDGilead Sciences, Inc. $132.73 -1.18% 17.57 $164.79B 2.46%
MRKMerck & Co., Inc. $128.57 +0.16% 31.37 $317.54B 2.92%

About Johnson & Johnson

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Johnson & Johnson is led by CEO Joaquin Duato, employs 138,100 people, headquartered in New Brunswick, US, publicly traded since 1943.

Johnson & Johnson (JNJ) stock trades at $259.24 with a market capitalization of $624.74B. The stock is valued at a price-to-earnings (P/E) ratio of 29.91, price-to-book of 7.81, price-to-sales of 6.48. Over the past 52 weeks the stock has ranged between $154.21 and $269.58, and currently trades 3.8% below its 52-week high. It pays a dividend yielding 2.07%.

On profitability, Johnson & Johnson generates a return on equity (ROE) of 26.26% — well above the market average, a sign of a high-quality business, return on capital employed of 18.08%, an operating margin of 26.87%, a net profit margin of 21.83%.

In its most recent fiscal year, Johnson & Johnson reported annual revenue of $94.2B, net profit of $26.8B, revenue has compounded at 2.7% a year over the last five years, profit at 12.7% a year. Profit growing faster than revenue points to expanding margins.

The balance sheet shows a debt-to-equity ratio of 0.68, a current ratio of 1.03, total assets of $199.2B, $19.7B in cash and equivalents.

JNJ has an average daily trading volume of 8,527,842.2 shares, a beta of 0.23 (less volatile than the overall market).

Official website: www.jnj.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06% DHR Medical - Diagnostics & Research $196.55 -1.26%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides